NOVO RESOURCES CORP. overview

Novo AI to Cut Costs and Boost Efficiency For Insurance Companies PR Newswire SINGAPORE, Aug. 14, 2024 SINGAPORE , Aug. 14, 2024 /PRNewswire/ -- Novo AI, founded by ex-Googlers and backed by First Round Capital, is revolutionizing the insurance industry with advanced generative AI technology. Their innovative solution is set to redefine operational efficiencies and profitability for insurance companies worldwide. Enhancing Efficiency and Reducing Costs An AI-native system designed to deliver...

Labcorp Receives FDA De Novo Marketing Authorization for PGDx elio™ plasma focus Dx PR Newswire BURLINGTON, N.C., Aug. 2, 2024 PGDx elio™ plasma focus Dx is the industry's first and only kitted, pan-solid tumor liquid biopsy test that enables tumor mutation profiling – all from a simple blood draw BURLINGTON, N.C. , Aug. 2, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today it has received De Novo marketing...

Novo Holdings leads $100 million Series C financing of Asceneuron to advance groundbreaking therapy for Alzheimer's disease PR Newswire COPENHAGEN, Denmark, July 16, 2024 Funds will be used to progress lead asset ASN51, an oral small molecule OGA inhibitor, into Phase 2 clinical development for the treatment of Alzheimer's disease Alzheimer's disease is an area of very high unmet medical need with a lack of oral disease modifying therapies Naveed Siddiqi , Senior Partner, Venture Investments,...

Novo Holdings co-leads £90 million ($114 million) Series A financing for Myricx Bio to advance a novel payload class for antibody-drug conjugates PR Newswire COPENHAGEN, Denmark, July 8, 2024 Funds will be used to build out Myricx Bio's proprietary payload platform and advance its pipeline through clinical proof of concept. Novo Holdings Venture Investments Partner Michael Bauer will join Myricx Board of Directors and Principal Max Klement will join Myricx Board as an Observer. This is the...

Novo Holdings invests in MATR Foods' expansion within plant-based fungi food PR Newswire COPENHAGEN, Denmark, July 1, 2024 COPENHAGEN, Denmark , July 1, 2024 /PRNewswire/ -- Today, Novo Holdings announced an initial investment in Danish food-tech start-up MATR Foods ('MATR') to support the scaling-up of its production of sustainable meat alternatives. Established in Copenhagen in 2021, MATR specialises in developing organic innovative plant-based meat alternatives using traditional fungal...

Amsino Medical Group announces transformational investment from Novo Tellus PR Newswire POMONA, Calif., June 27, 2024 POMONA, Calif., June 27, 2024 /PRNewswire/ -- Amsino Medical Group ("Amsino"), a global provider of medical consumable devices, is pleased to announce the closing of a substantial investment by Novo Tellus, a leading investment firm specialising in long-term investments in the global supply chain. Novo Tellus is deeply familiar with Amsino, having previously partnered with Amsino...

Novo Holdings and DLG Group join forces to advance sustainable crop production PR Newswire COPEHAGEN, Denmark, June 27, 2024 COPEHAGEN, Denmark , June 27, 2024 /PRNewswire/ -- Novo Holdings and DLG Group today announced a strategic partnership to advance sustainable agriculture and food systems. The initial phase includes Novo Holdings acquiring 25% of the shares in Sejet Plant Breeding (Sejet), a leader in agricultural innovation owned by DLG Group. Since 1947, Sejet has been a leading...

Amsino Medical Group announces transformational investment from Novo Tellus PR Newswire POMONA, Calif., June 27, 2024 POMONA, Calif., June 27, 2024 /PRNewswire/ -- Amsino Medical Group ("Amsino"), a global provider of medical consumable devices, is pleased to announce the closing of a substantial investment by Novo Tellus, a leading investment firm specialising in long-term investments in the global supply chain. Novo Tellus is deeply familiar with Amsino, having previously partnered with Amsino...